Comparative analysis of large language models: ChatGPT and Google Bard answer nonexpert questions related to the diagnostic and therapeutic applications of prostate-specific membrane antigen (PSMA) in patients with prostate cancer

被引：0
|
作者：
Hong, Julie [1 ]
Calais, Jeremie [1 ]
Benz, Matthias [1 ]
Auerbach, Martin
Salavati, Ali [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242416
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis
    Offermann, Anne
    Hupe, Marie Christine
    Roth, Doris
    Kuempers, Christiane
    Ribbat-Idel, Julika
    Becker, Finn
    Joerg, Vincent
    Merseburger, Axel
    Kirfel, Jutta
    Sailer, Verena
    Perner, Sven
    LABORATORY INVESTIGATION, 2019, 99
  • [12] Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
    Hupe, Marie Christine
    Philippi, Christian
    Roth, Doris
    Kuempers, Christiane
    Ribbat-Idel, Julika
    Becker, Finn
    Joerg, Vincent
    Duensing, Stefan
    Lubczyk, Verena Helena
    Kirfel, Jutta
    Sailer, Verena
    Kuefer, Rainer
    Merseburger, Axel Stuart
    Perner, Sven
    Offermann, Anne
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [13] Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance
    Ahmadi, Elham
    Wang, Simon
    Gouran-Savadkoohi, Mohammad
    Douvi, Georgia
    Isfahanian, Naghmeh
    Tsakiridis, Nicole
    Faught, Brent E.
    Cutz, Jean-Claude
    Sur, Monalisa
    Chawla, Satish
    Pond, Gregory R.
    Steinberg, Gregory R.
    Brown, Ian
    Tsakiridis, Theodoros
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [14] Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis
    Offermann, A.
    Hupe, M. C.
    Philippi, C.
    Joerg, V.
    Becker, F.
    Kirfel, J.
    Merseburger, A. S.
    Perner, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 47 - 47
  • [15] The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
    Guler, O. C.
    Engels, B.
    Onal, C.
    Everaert, H.
    Van den Begin, R.
    Gevaert, T.
    de Ridder, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (04): : 484 - 490
  • [16] The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
    O. C. Guler
    B. Engels
    C. Onal
    H. Everaert
    R. Van den Begin
    T. Gevaert
    M. de Ridder
    Clinical and Translational Oncology, 2018, 20 : 484 - 490
  • [17] Diagnostic Utility Of Lutetium-177 (Lu 177) Prostate-Specific Membrane Antigen (PSMA) Scintigraphy In Prostate Cancer Patients With PSA Rise And Negative Conventional Imaging
    Ghodsirad, Mohammad Ali
    Pirayesh, Elaheh
    Akbarian, Ramin
    Javanmard, Babak
    Kaghazchi, Fatemeh
    Tavakoli, Mehrdad
    Fattahi, Kourosh
    UROLOGY JOURNAL, 2020, 17 (04) : 374 - 378
  • [18] The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities
    Franzese, Elisena
    De Falco, Stefano
    Laterza, Maria Maddalena
    Montella, Liliana
    Facchini, Sergio
    Liguori, Carmela
    Coppola, Paola
    Diessa, Ylenia
    Berretta, Massimiliano
    Pisconti, Salvatore
    Trama, Francesco
    Ferro, Matteo
    Crocetto, Felice
    Fasano, Morena
    Buonerba, Carlo
    Facchini, Gaetano
    FUTURE SCIENCE OA, 2021, 7 (06):
  • [19] Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
    Kabasakal, Levent
    AbuQbeitah, Mohammad
    Aygun, Aslan
    Yeyin, Nami
    Ocak, Meltem
    Demirci, Emre
    Toklu, Turkay
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (13) : 1976 - 1983
  • [20] Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
    Levent Kabasakal
    Mohammad AbuQbeitah
    Aslan Aygün
    Nami Yeyin
    Meltem Ocak
    Emre Demirci
    Turkay Toklu
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1976 - 1983
12345